Taken together, these results discussed the multiple strategies to target BCL-2 family proteins of the intrinsic mitochondrial apoptotic pathway and present new windows and opportunities for future therapeutic options in childhood cancers. Here, BCL2 is linked to childhood malignant neoplasm.